Ontology highlight
ABSTRACT: Background
The COVID-19 pandemic has profoundly affected impacted both physical and mental well-being. This matched cohort study investigated the effects of COVID-19 on pharmacological treatments for insomnia, using Japan's National Insurance Claims Database.Methods
Data were matched by age, sex, Charlson Comorbidity Index (CCI) score, and enrollment month. Incidence rate ratios (IRR) and incidence rate differences (IRD) were calculated and compared for insomnia medication initiation, and subgroups based on age and sex categories. Sensitivity analyses were conducted for segmented intervals of 0-4, 5-12, and after 12 months.Results
The study included approximately 2 million pairs, predominantly women (59.4%), with a median follow-up of 7 months (Interquartile range,
SUBMITTER: Miyamori D
PROVIDER: S-EPMC12826487 | biostudies-literature | 2026
REPOSITORIES: biostudies-literature